About TRWR
19474
page-template,page-template-full_width,page-template-full_width-php,page,page-id-19474,bridge-core-3.0.1,qodef-qi--no-touch,qi-addons-for-elementor-1.5.1,, vertical_menu_transparency vertical_menu_transparency_on,side_area_uncovered_from_content,qode-theme-ver-28.5,qode-theme-bridge,transparent_content,disabled_footer_bottom,wpb-js-composer js-comp-ver-6.7.0,vc_responsive,elementor-default,elementor-kit-5,elementor-page elementor-page-19474
 

About TRWR

Who we are

Taiwan Resonant Waves Research Corp.(TRWR) was founded in 2010 in the capital of Taiwan – Taipei. Integrating innovative bioelectronic technology with medical devices, we are dedicated to helping patients with chronic diseases better manage health-related challenges.

 

There is unlimited promise in the application of bioelectronic medicine in the treatment of chronic diseases. Designed and developed by TRWR, Microcurrent Electrical Nerve Stimulation technology (MENS) is currently being used as a non-invasive, physical approach to treating and alleviating symptoms associated with diabetes mellitus.

Our Vision

Our vision is to establish global presence as a Taiwanese brand through strategic collaborations and partnerships around the world. We strive to continually advance our core competences in Diabetes-MENS technology and expand our patent portfolio.

Our Mission

We are committed to addressing the unmet medical needs of those suffering from chronic diseases by pursuing advancements in bioelectronic technology and delivering cost-effective healthcare solutions.

The latest TRWR job vacancies, welcome to join us! ​

With the lifelong passion for beloved Taiwan, we step out firmly to the globe.


With the successful development of bioelectronic medicine, we will create a blue ocean in healthcare industry.


Helping people stay healthy is always our faith.

Chairman

DR.

huang-signature

COMPANY MILESTONES

2021

September 2021 The on-site GCP audition of “Prospective, double-blind, randomized, placebo-controlled trial of Transcutaneous Electrical Nerve Stimulator (DW1330) to improve blood glucose control in patients with type 2 diabetes” was completed in National Taiwan University Hospital.

2020

May 2014 DM-ELF Diabetes Bioelectronic Medicine (DM520) obtained the certification of medical electrical equipment: general requirements for basic safety and essential performance - collateral standard: electromagnetic disturbances - requirements and tests (IEC 60601-1, IEC 60601-1-2, IEC 60601-1-11, IEC 60601-2-10, AAMI-NS4).
November 2020 DM-ELF Diabetes Bioelectronic Medicine (DM520) passed ISO 13485:2016 audit and certified with certificate TW20/10567.。

2019

February 2019 Acquired pharmaceutical product license (no. 640110C374)
October 2019 Commenced both software and hardware development of optimized diabetes bioelectronic medicine.

2018

June 2018 TRWR won first prize for Innovation Challenge at the 2018 RESI (Redefining Early Stage Investments) Conference in Boston.
 
August 2018 The commissioned manufacturer of “Dragon Waves Resonant Home Care Electronic Nerve Stimulator” (DW1330) relocated and obtained medical device license no. 006169 with blood circulation, pain relief, and relaxation functions.

2017

April 2017 National Taiwan University Hospital and National Cheng Kung University Hospital, in collaboration with two other medical facilities, has begun a prospective, double-blind, randomized, placebo-controlled trial of Transcutaneous Electrical Nerve Stimulator (DW1330) to improve blood glucose control in patients with type 2 diabetes.

2014

January 2014 – December 2015 Conducted a single-blind, randomized study at Saint Mary's Hospital Luodong on the effects of "Dragon Waves Resonant Home Care Electronic Nerve Stimulator” (DW1330) on improving blood glucose control in patients with type 2 diabetes (sample size of 80).
 
April 2014 Acquired certification of medical electrical equipment - general requirements for basic safety and essential performance (IEC 60601-1, IEC 60601-1-11, IEC 60601-2-10).
 
May 2014 Obtained the certification of medical electrical equipment: general requirements for basic safety and essential performance - collateral standard: electromagnetic disturbances - requirements and tests (IEC60601-1-2:2007).

2013

March 2013 Launched “Dragon Waves Resonant Home Care Electronic Nerve Stimulator” (DW1330) and obtained medical device license no. 003997 with blood circulation, pain relief, and relaxation functions.
 
July 2013 Completed a study on patients with type 2 diabetes from Luodong Neng-Chun Diabetes Clinic.

2012

August 2012 Acquired pharmaceutical product license (no. 620117J595).
 
October 2012 Development of “Dragon Waves Resonant Home Care Electronic Nerve Stimulator” (DW1330) was completed.

2011

September 2011 Commenced both software and hardware development of “Dragon Waves Resonant Home Care Electronic Nerve Stimulator” (DW1330).

2010

Business registered.

2009

Found in Taipei.